Medicare’s New $2,000 Drug Cap in 2026: What It Means for You
Quick Answer Starting in 2025, Medicare Part D will feature a $2,000 annual out-of-pocket cap on covered prescription drugs. Once your spending reaches $2,000 in a calendar year, you will pay $0 for all covered drugs for the remainder of the year. This marks one of the most significant improvements to Medicare drug benefits in decades, particularly benefiting those who rely on costly medications for conditions such as cancer, diabetes, and arthritis.
$2,0002026 Part D out-of-pocket cap
$0Your cost after reaching the cap
3.2MBeneficiaries projected to benefit annually
For years, Medicare Part D had a significant flaw: once your drug spending exceeded a certain threshold — known as the “donut hole” — your costs would actually increase. The Affordable Care Act of 2010 began to address this issue, but it wasn’t until the Inflation Reduction Act of 2022 that Congress established a true out-of-pocket cap.
This cap is now in effect. Here’s a detailed look at how it works and its implications for your Medicare drug coverage.
What Changed With Part D in 2025 and 2026
The Inflation Reduction Act (IRA) of 2022 brought several changes to Medicare Part D over multiple years:
| Year | IRA Change | Impact |
|---|---|---|
| 2023 | Insulin capped at $35/month | Lower costs for diabetics |
| 2024 | Manufacturer discounts in catastrophic phase required | Reduced plan costs in high-spend years |
| 2025 | $2,000 out-of-pocket cap introduced; M3P available | Hard cap on annual drug spending for the first time ever |
| 2026 | Cap continues; Medicare drug price negotiations take effect for more drugs | Lower formulary costs on negotiated drugs |
The cap will take effect on January 1, 2025. In 2026, the standard Part D out-of-pocket cap will remain at $2,000. While some plans may set lower caps, no Medicare drug plan can exceed this threshold.
How the $2,000 Cap Works
The cap operates on a straightforward principle: track your total out-of-pocket spending on covered Part D drugs throughout the year. Once your total reaches $2,000, you enter the catastrophic phase and pay nothing for covered drugs for the remainder of the calendar year.
The clock resets every January 1.
💡 Example: If you take a specialty drug for rheumatoid arthritis costing $400 per month in copays, by May, you’ll have spent $2,000 out-of-pocket. From June through December — seven months — you will pay $0 at the pharmacy for that drug and any other covered Part D medication. Your plan will absorb the cost.
What Counts Toward the $2,000 Cap
Not every dollar spent on prescription drugs counts toward the $2,000 threshold. Here’s a breakdown:
| Spending Type | Counts Toward Cap? |
|---|---|
| Annual Part D deductible (paid at the pharmacy) | ✅ Yes |
| Copays and coinsurance for covered drugs | ✅ Yes |
| Monthly Part D premiums | ❌ No |
| Drugs NOT on your plan’s formulary | ❌ No |
| Over-the-counter medications | ❌ No |
| Extra Help / Low Income Subsidy amounts | ❌ No |
| Manufacturer discount program amounts (on covered drugs) | ✅ Yes (new rule for 2025+) |
The inclusion of manufacturer discounts as counting toward the cap is a significant change from previous years. Previously, these discounts did not count toward beneficiary spending totals, which delayed many individuals’ access to catastrophic coverage. This change takes effect in 2025.
The Three Phases of Part D Coverage in 2026
1
Deductible phase
You pay 100% of drug costs until you meet your plan’s deductible. The standard 2026 deductible is up to $590, although many plans set it lower or waive it for certain tiers.
2
Initial coverage phase
After meeting your deductible, you pay your plan’s copays or coinsurance. Your plan covers the rest. This phase continues until you’ve spent $2,000 out-of-pocket.
3
Catastrophic phase (the cap) ✓
Once you’ve spent $2,000 out-of-pocket on covered drugs, you pay $0 for the rest of the calendar year. No copays, no coinsurance — zero. This is a new feature as of 2025.
📌 The donut hole is gone. The coverage gap (donut hole) that existed from 2006–2024 — where beneficiaries faced significantly higher costs — has been eliminated. The 2026 Part D structure transitions directly from the initial coverage phase to the catastrophic (zero-cost) phase once you hit $2,000.
Who Benefits Most From the $2,000 Cap
The cap is advantageous for anyone taking expensive medications, but certain groups will benefit significantly more:
People on specialty drugs
Specialty medications for conditions like cancer, multiple sclerosis, and rheumatoid arthritis can cost between $5,000 and $30,000 per month. Previously, beneficiaries could spend over $10,000 out-of-pocket annually. With the new cap, their maximum out-of-pocket expense is now $2,000 — a transformative change.
Diabetics on GLP-1 medications
Medications like Ozempic and Mounjaro, covered by Part D for diabetes, can cost $40–$150 per month in copays. High-tier specialty placement may lead beneficiaries to reach the $2,000 cap by mid-year, after which their costs drop to zero. Insulin remains capped at $35/month regardless of benefit phases.
Anyone with multiple chronic conditions
Seniors managing five or more medications — common for those with heart disease, diabetes, COPD, and arthritis — will accumulate Part D spending quickly. The cap offers a predictable annual ceiling for budgeting.
People who previously skipped medications due to cost
Studies show that Medicare beneficiaries who hit the old donut hole often skipped doses or ceased taking medications to manage costs. The $2,000 cap is expected to significantly reduce this risky behavior.
The Medicare Prescription Payment Plan (M3P)
Even with a $2,000 annual cap, hitting it early in the year can feel burdensome. Paying $2,000 in just two months can be challenging, even if you pay $0 for the rest of the year.
To alleviate this, the Inflation Reduction Act introduced the Medicare Prescription Payment Plan (M3P), effective in 2025. M3P allows you to spread your out-of-pocket drug costs across equal monthly payments throughout the year, rather than facing large bills at the pharmacy.
How M3P works
- You must opt in through your Part D plan (it’s not automatic)
- Instead of large copays at the pharmacy, you pay a calculated monthly amount spread over the year
- Your plan will bill you monthly, similar to a phone bill
- Your total annual spending remains unchanged — only the distribution changes
- M3P is particularly beneficial for those likely to hit the $2,000 cap (e.g., specialty drug users)
To enroll in M3P, contact your Part D plan directly. You can switch in or out of M3P during specific times of the year.
Does the $2,000 Cap Apply to Medicare Advantage Plans?
Yes. If you have a Medicare Advantage plan with drug coverage (an MA-PD plan), the $2,000 out-of-pocket cap applies to the drug benefit portion of your plan. This federal law is uniformly applicable to all Medicare drug coverage — both standalone Part D plans and MA-PD plans.
Keep in mind that Medicare Advantage plans have a separate out-of-pocket maximum for medical services (doctor visits, hospital stays, etc.). This limit differs from the drug cap and is set by CMS each year. In 2026, the Medicare Advantage maximum out-of-pocket for in-network medical services is $9,350.
| Coverage Type | Drug Cap (2026) | Medical OOP Max (2026) |
|---|---|---|
| Standalone Part D (with Original Medicare) | $2,000 | No cap on medical (Medigap recommended) |
| Medicare Advantage + Drug (MA-PD) | $2,000 for drugs | Up to $9,350 for medical (in-network) |
Find a Part D plan that minimizes your drug costs
Different plans charge varying copays for the same drugs. A licensed specialist can help compare plans in your area based on your specific medications.
Frequently Asked Questions
What is the Medicare Part D out-of-pocket cap in 2026?
The 2026 Medicare Part D out-of-pocket cap is $2,000. Once your annual out-of-pocket spending on covered prescription drugs reaches this amount, you will pay $0 for the rest of the calendar year.
Does the $2,000 cap apply to Medicare Advantage drug plans?
Yes, the cap applies to both standalone Part D plans and Medicare Advantage plans that include drug coverage (MA-PD plans).
Do premiums count toward the $2,000 cap?
No, monthly Part D premiums do not count toward the out-of-pocket cap. Only your cost-sharing payments at the pharmacy (deductibles, copays, coinsurance) count.
What is the Medicare Prescription Payment Plan (M3P)?
M3P is an optional program that allows you to spread your Part D drug costs across equal monthly payments throughout the year, rather than paying large amounts at the pharmacy. You must opt in through your plan — it is not automatic.
Is the donut hole still a thing in 2026?
No, the Medicare Part D coverage gap (donut hole) has been eliminated as of 2025. Part D now transitions directly from the initial coverage phase to the catastrophic phase (zero-cost) once you’ve spent $2,000.
Does the $2,000 cap reset every year?
Yes, your out-of-pocket spending resets to $0 on January 1 each year. You must reach $2,000 again in the new year to re-enter the catastrophic (zero-cost) phase.
Quick Answer Starting in 2025, Medicare Part D will feature a $2,000 annual out-of-pocket cap on covered prescription drugs. Once your spending reaches $2,000 in a calendar year, you will pay $0 for all covered drugs for the remainder of the year. This marks one of the most significant improvements to Medicare drug benefits in decades, particularly benefiting those who rely on costly medications for conditions such as cancer, diabetes, and arthritis.
$2,0002026 Part D out-of-pocket cap
$0Your cost after reaching the cap
3.2MBeneficiaries projected to benefit annually
For years, Medicare Part D had a significant flaw: once your drug spending exceeded a certain threshold — known as the “donut hole” — your costs would actually increase. The Affordable Care Act of 2010 began to address this issue, but it wasn’t until the Inflation Reduction Act of 2022 that Congress established a true out-of-pocket cap.
This cap is now in effect. Here’s a detailed look at how it works and its implications for your Medicare drug coverage.
What Changed With Part D in 2025 and 2026
The Inflation Reduction Act (IRA) of 2022 brought several changes to Medicare Part D over multiple years:
| Year | IRA Change | Impact |
|---|---|---|
| 2023 | Insulin capped at $35/month | Lower costs for diabetics |
| 2024 | Manufacturer discounts in catastrophic phase required | Reduced plan costs in high-spend years |
| 2025 | $2,000 out-of-pocket cap introduced; M3P available | Hard cap on annual drug spending for the first time ever |
| 2026 | Cap continues; Medicare drug price negotiations take effect for more drugs | Lower formulary costs on negotiated drugs |
The cap will take effect on January 1, 2025. In 2026, the standard Part D out-of-pocket cap will remain at $2,000. While some plans may set lower caps, no Medicare drug plan can exceed this threshold.
How the $2,000 Cap Works
The cap operates on a straightforward principle: track your total out-of-pocket spending on covered Part D drugs throughout the year. Once your total reaches $2,000, you enter the catastrophic phase and pay nothing for covered drugs for the remainder of the calendar year.
The clock resets every January 1.
💡 Example: If you take a specialty drug for rheumatoid arthritis costing $400 per month in copays, by May, you’ll have spent $2,000 out-of-pocket. From June through December — seven months — you will pay $0 at the pharmacy for that drug and any other covered Part D medication. Your plan will absorb the cost.
What Counts Toward the $2,000 Cap
Not every dollar spent on prescription drugs counts toward the $2,000 threshold. Here’s a breakdown:
| Spending Type | Counts Toward Cap? |
|---|---|
| Annual Part D deductible (paid at the pharmacy) | ✅ Yes |
| Copays and coinsurance for covered drugs | ✅ Yes |
| Monthly Part D premiums | ❌ No |
| Drugs NOT on your plan’s formulary | ❌ No |
| Over-the-counter medications | ❌ No |
| Extra Help / Low Income Subsidy amounts | ❌ No |
| Manufacturer discount program amounts (on covered drugs) | ✅ Yes (new rule for 2025+) |
The inclusion of manufacturer discounts as counting toward the cap is a significant change from previous years. Previously, these discounts did not count toward beneficiary spending totals, which delayed many individuals’ access to catastrophic coverage. This change takes effect in 2025.
The Three Phases of Part D Coverage in 2026
1
Deductible phase
You pay 100% of drug costs until you meet your plan’s deductible. The standard 2026 deductible is up to $590, although many plans set it lower or waive it for certain tiers.
2
Initial coverage phase
After meeting your deductible, you pay your plan’s copays or coinsurance. Your plan covers the rest. This phase continues until you’ve spent $2,000 out-of-pocket.
3
Catastrophic phase (the cap) ✓
Once you’ve spent $2,000 out-of-pocket on covered drugs, you pay $0 for the rest of the calendar year. No copays, no coinsurance — zero. This is a new feature as of 2025.
📌 The donut hole is gone. The coverage gap (donut hole) that existed from 2006–2024 — where beneficiaries faced significantly higher costs — has been eliminated. The 2026 Part D structure transitions directly from the initial coverage phase to the catastrophic (zero-cost) phase once you hit $2,000.
Who Benefits Most From the $2,000 Cap
The cap is advantageous for anyone taking expensive medications, but certain groups will benefit significantly more:
People on specialty drugs
Specialty medications for conditions like cancer, multiple sclerosis, and rheumatoid arthritis can cost between $5,000 and $30,000 per month. Previously, beneficiaries could spend over $10,000 out-of-pocket annually. With the new cap, their maximum out-of-pocket expense is now $2,000 — a transformative change.
Diabetics on GLP-1 medications
Medications like Ozempic and Mounjaro, covered by Part D for diabetes, can cost $40–$150 per month in copays. High-tier specialty placement may lead beneficiaries to reach the $2,000 cap by mid-year, after which their costs drop to zero. Insulin remains capped at $35/month regardless of benefit phases.
Anyone with multiple chronic conditions
Seniors managing five or more medications — common for those with heart disease, diabetes, COPD, and arthritis — will accumulate Part D spending quickly. The cap offers a predictable annual ceiling for budgeting.
People who previously skipped medications due to cost
Studies show that Medicare beneficiaries who hit the old donut hole often skipped doses or ceased taking medications to manage costs. The $2,000 cap is expected to significantly reduce this risky behavior.
The Medicare Prescription Payment Plan (M3P)
Even with a $2,000 annual cap, hitting it early in the year can feel burdensome. Paying $2,000 in just two months can be challenging, even if you pay $0 for the rest of the year.
To alleviate this, the Inflation Reduction Act introduced the Medicare Prescription Payment Plan (M3P), effective in 2025. M3P allows you to spread your out-of-pocket drug costs across equal monthly payments throughout the year, rather than facing large bills at the pharmacy.
How M3P works
- You must opt in through your Part D plan (it’s not automatic)
- Instead of large copays at the pharmacy, you pay a calculated monthly amount spread over the year
- Your plan will bill you monthly, similar to a phone bill
- Your total annual spending remains unchanged — only the distribution changes
- M3P is particularly beneficial for those likely to hit the $2,000 cap (e.g., specialty drug users)
To enroll in M3P, contact your Part D plan directly. You can switch in or out of M3P during specific times of the year.
Does the $2,000 Cap Apply to Medicare Advantage Plans?
Yes. If you have a Medicare Advantage plan with drug coverage (an MA-PD plan), the $2,000 out-of-pocket cap applies to the drug benefit portion of your plan. This federal law is uniformly applicable to all Medicare drug coverage — both standalone Part D plans and MA-PD plans.
Keep in mind that Medicare Advantage plans have a separate out-of-pocket maximum for medical services (doctor visits, hospital stays, etc.). This limit differs from the drug cap and is set by CMS each year. In 2026, the Medicare Advantage maximum out-of-pocket for in-network medical services is $9,350.
| Coverage Type | Drug Cap (2026) | Medical OOP Max (2026) |
|---|---|---|
| Standalone Part D (with Original Medicare) | $2,000 | No cap on medical (Medigap recommended) |
| Medicare Advantage + Drug (MA-PD) | $2,000 for drugs | Up to $9,350 for medical (in-network) |
Find a Part D plan that minimizes your drug costs
Different plans charge varying copays for the same drugs. A licensed specialist can help compare plans in your area based on your specific medications.
Frequently Asked Questions
What is the Medicare Part D out-of-pocket cap in 2026?
The 2026 Medicare Part D out-of-pocket cap is $2,000. Once your annual out-of-pocket spending on covered prescription drugs reaches this amount, you will pay $0 for the rest of the calendar year.
Does the $2,000 cap apply to Medicare Advantage drug plans?
Yes, the cap applies to both standalone Part D plans and Medicare Advantage plans that include drug coverage (MA-PD plans).
Do premiums count toward the $2,000 cap?
No, monthly Part D premiums do not count toward the out-of-pocket cap. Only your cost-sharing payments at the pharmacy (deductibles, copays, coinsurance) count.
What is the Medicare Prescription Payment Plan (M3P)?
M3P is an optional program that allows you to spread your Part D drug costs across equal monthly payments throughout the year, rather than paying large amounts at the pharmacy. You must opt in through your plan — it is not automatic.
Is the donut hole still a thing in 2026?
No, the Medicare Part D coverage gap (donut hole) has been eliminated as of 2025. Part D now transitions directly from the initial coverage phase to the catastrophic phase (zero-cost) once you’ve spent $2,000.
Does the $2,000 cap reset every year?
Yes, your out-of-pocket spending resets to $0 on January 1 each year. You must reach $2,000 again in the new year to re-enter the catastrophic (zero-cost) phase.
